Free Trial

Fulgent Genetics (FLGT) Earnings Date, Estimates & Call Transcripts

Fulgent Genetics logo
$18.78 -0.78 (-3.96%)
As of 02:56 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Fulgent Genetics Earnings Summary

Latest Q1 2025
Earnings Date
May. 2Estimated
Consensus EPS
(May. 2)
-$0.18
Actual EPS
(May. 2)
$0.04 Beat By $0.22
Actual Revenue
(May. 2)
$73.46M

Fulgent Genetics posted Q1 2025 earnings on May 2, 2025, reporting an EPS of $0.04, which beat analysts' consensus estimates of -$0.18 by $0.22. Quarterly revenue rose 14.0% year-over-year to $73.46 million, above the consensus estimate of $71.26 million. With a trailing EPS of -$1.41, Fulgent Genetics' earnings are expected to decrease next year, from ($0.85) to ($1.25) per share.

Q1 2025 Earnings Resources

Get Fulgent Genetics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Fulgent Genetics and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

FLGT Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

FLGT Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Fulgent Genetics Analyst EPS Estimates

Current Year EPS Consensus Estimate
($0.85) EPS
Next Year EPS Consensus Estimate
($1.25) EPS

Fulgent Genetics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
5/2/2025Q1 2025-$0.18$0.04+$0.22-$0.37$71.26M$73.46M
8/2/2024Q2 2024-$0.30$0.15+$0.45-$0.15$69.07M$71.03M
5/3/2024Q1 2024-$0.58-$0.38+$0.20-$0.31$65.74M$64.49M
2/28/2024Q4 2023-$0.63-$0.02+$0.61$4.26$67.14M$70.51M
11/3/2023Q3 2023-$0.32-$0.39 -$0.07-$0.42$64.42M$84.70M
8/4/2023Q2 2023-$0.59-$0.33+$0.26-$0.28$62.68M$67.85M

Fulgent Genetics Earnings - Frequently Asked Questions

Fulgent Genetics (NASDAQ:FLGT) last announced its quarterly earning data on Friday, May 2, 2025. Learn more on FLGT's earnings history.

Fulgent Genetics updated its FY 2025 earnings guidance on Friday, May, 2nd. The company provided earnings per share guidance of -0.650--0.65 for the period, compared to the consensus estimate of -0.660. The company issued revenue guidance of $310.0 million-$310.0 million, compared to the consensus revenue estimate of $310.4 million.

In the previous quarter, Fulgent Genetics (NASDAQ:FLGT) reported $0.04 earnings per share (EPS) to beat the analysts' consensus estimate of ($0.18) by $0.22. Learn more on analysts' earnings estimate vs. FLGT's actual earnings.

Fulgent Genetics (NASDAQ:FLGT) has a recorded annual revenue of $283.47 million.

Fulgent Genetics (NASDAQ:FLGT) has a recorded net income of -$167.82 million. FLGT has generated -$1.41 earnings per share over the last four quarters.

Fulgent Genetics's earnings are expected to decrease from ($0.85) per share to ($1.25) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:FLGT) was last updated on 5/6/2025 by MarketBeat.com Staff
From Our Partners